Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549991 · ClinicalTrials.gov registry record
Analyzing Genes That May Increase the Risk of Developing High Blood Pressure
A clinical trial, sponsored by Case Western Reserve University.
- Completed
- Registry status
- 8,687
- Enrollment target
NCT00549991: Completed study, sponsored by Case Western Reserve University.
NCT00549991 is a clinical trial that has completed, run by Case Western Reserve University. The registered enrollment target is 8,687 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00549991 has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- 8,687 participants
- Enrollment target
Study Summary
High blood pressure is one of the most common health problems in the United States. Genetic variations may cause some people to be more susceptible to developing high blood pressure. This study will identify variations in genes known to play a part in the development of high blood pressure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,687 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-06 |
What the finished NCT00549991 record still lists
NCT00549991 is an observational study that tracks outcomes without assigning an intervention. Its 8,687 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00549991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00549991 about?
NCT00549991 is a clinical study titled "Analyzing Genes That May Increase the Risk of Developing High Blood Pressure". High blood pressure is one of the most common health problems in the United States. Genetic variations may cause some people to be more susceptible to developing high blood pressure. This study will identify variations in genes known to play a part in the development of high blood pressure.
What is the current status of trial NCT00549991?
This trial is currently completed. The enrollment target is 8,687 participants. The study started on 2007-08. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00549991?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia